Pirtobrutinib efficacy in covalent BTK-inhibitor pre-treated relapsed/refractory CLL/SLL: Additional patients and extended follow-up from BRUIN
Talha Munir,Anthony R. Mato,Jennifer A. Woyach,Jennifer R. Brown,Paolo Ghia,Krish Patel,Toby A. Eyre,Ewa Lech-Maranda,Nicole Lamanna,Constantine S. Tam,John F. Seymour, Nirav N. Shah,Catherine C. Coombs,Chaitra S. Ujjani,Manish R. Patel,Bita Fakhri,Chan Y. Cheah,Alvaro J. Alencar,Jonathon B. Cohen,James N. Gerson,Ian W. Flinn,Shuo Ma,Deepa Jagadeesh,Joanna M. Rhodes,Francisco Hernandez-Ilizaliturri,Pier Luigi Zinzani,Minna Balbas,Binoj Nair,Paolo Abada,Chunxiao Wang,Denise Wang,Donald E. Tsai,William G. Wierda,Wojciech Jurczak BRITISH JOURNAL OF HAEMATOLOGY（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
